Sonoma Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Sonoma Pharmaceuticals

12/02/2024 22:02

* Sonoma Pharmaceuticals Inc  SNOA.OQ  reported a quarterly
adjusted loss of 8 cents​​ per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of -62 cents.  The lone analyst forecast
for the quarter was for a loss of 21 cents per share. 
    * Revenue rose 6.6% to $3.14 million from a year ago;
analysts
expected $3.76 million. 
    * Sonoma Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 8 cents​.
    * The company reported a quarterly loss of $866 thousand.
    * Sonoma Pharmaceuticals Inc shares had fallen by 11.9% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "strong buy"

Wall Street's median 12-month price target for Sonoma
Pharmaceuticals Inc is $3.25 
This summary was machine generated from LSEG data February 12 at
10:02 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.21          -0.08          Beat
 Sep. 30 2023      -0.24          -0.29          Missed
                                  -0.29          
                                  -0.31